A study of proteases and protease-inhibitor complexes in biological fluids.
about
Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finAn active-site titrant for human tissue-type plasminogen activatorImmunocytochemical demonstration of tissue-type plasminogen activator in endocrine cells of the rat pituitary glandAccessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitorUrothelial function reconsidered: a role in urinary protein secretionTissue-type plasminogen activator requires a co-receptor to enhance NMDA receptor function.Deposits of alpha 2M in the rheumatoid synovial membrane.A milk protein gene promoter directs the expression of human tissue plasminogen activator cDNA to the mammary gland in transgenic miceExpression of active recombinant human tissue-type plasminogen activator by using in vivo polyhydroxybutyrate granule display.Plasminogen-activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells.Decrease in plasminogen activator correlates with synapse elimination during neonatal development of mouse skeletal muscle.A 170-kDa membrane-bound protease is associated with the expression of invasiveness by human malignant melanoma cellsSuppression of urokinase-type plasminogen activator mRNA levels in human fibrosarcoma cells and synovial fibroblasts by anti-inflammatory glucocorticoids.Involvement of finger domain and kringle 2 domain of tissue-type plasminogen activator in fibrin binding and stimulation of activity by fibrinCytokines induce urokinase-dependent adhesion of human myeloid cells. A regulatory role for plasminogen activator inhibitors.A plasminogen activator is induced during goldfish optic nerve regenerationProduction of plasminogen activator by migrating cephalic neural crest cellsTumor promoter PMA stimulates the synthesis and secretion of mouse pro-urokinase in MSV-transformed 3T3 cells: this is mediated by an increase in urokinase mRNA content.Characterization of alkylamine-sensitive site in alpha 2-macroglobulin.Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery diseaseSystemic lysis protects against the effects of platelet activation during coronary thrombolysis.Plasminogen activators in human colorectal neoplasia.Functional inhibition of endogenously produced urokinase decreases cell proliferation in a human melanoma cell line.Zymography methods for visualizing hydrolytic enzymes.Functional characterization of recombinant batroxobin, a snake venom thrombin-like enzyme, expressed from Pichia pastoris.Induction of brain microvascular endothelial cell urokinase expression by Cryptococcus neoformans facilitates blood-brain barrier invasionThrombin stimulates tissue plasminogen activator release from cultured human endothelial cellsTissue-type plasminogen activator increases the binding of glu-plasminogen to clotsReduction-oxidation (redox) state regulation of extracellular matrix metalloproteinases and tissue inhibitors in cardiac normal and transformed fibroblast cells.Metalloproteases of infective Ancylostoma hookworm larvae and their possible functions in tissue invasion and ecdysisA continuous-exchange cell-free protein synthesis system based on extracts from cultured insect cells.Soluble expression, purification, and characterization of active recombinant human tissue plasminogen activator by auto-induction in E. coliReleased protease-nexin regulates cellular binding, internalization, and degradation of serine proteases.Effects of sulfonylureas on the synthesis and secretion of plasminogen activator from bovine aortic endothelial cellsIncreased plasminogen activator inhibitor-1 in keloid fibroblasts may account for their elevated collagen accumulation in fibrin gel culturesSites of synthesis of urokinase and tissue-type plasminogen activators in the murine kidney.Induction of acalculous cholecystitis and pneumonitis in dogs following inhalation of constituents of cigarette smoke condensate.Tissue-type plasminogen activator in plasma from breast cancer patients determined by enzyme-linked immunosorbent assay.Characterization of seven human melanoma cell lines: melanogenesis and secretion of plasminogen activators.The Influence of Differentially Expressed Tissue-Type Plasminogen Activator in Experimental Autoimmune Encephalomyelitis: Implications for Multiple Sclerosis.
P2860
Q24300911-EE5FDC4B-BD68-4B39-BB77-B1A423EF10B9Q28360835-E9DE58C9-9D7F-41C1-A04C-7A4B1F3AE2FCQ28583880-21F5FA5F-CB07-4E7B-9B0B-3DFC987A733AQ28647054-AFB595E2-B2CF-480A-B7CE-EC1D40DA93B2Q30641854-DA39A8BD-79EC-4BD3-B97C-DF6F0C2FFF8CQ33369942-79F4D46B-C29C-453E-8CB5-BF91FA2CADE5Q33554004-C528CDE0-7029-40C1-94E8-D6292BB1B654Q33638859-E475FC20-11FB-4A0B-8641-497B9F5CA09EQ33690400-4B47F515-6CE3-41F1-B65C-FD1A19D73CBCQ33781945-37B78B76-AA2F-4645-A2D4-C473DBBE4866Q33830088-479BC0BD-12F5-4E80-A677-EE9FB7F607FBQ33862813-FB7BD6E8-33ED-48AE-9729-9AC319538D94Q33880338-EB712BB6-9BE6-4A02-B789-8CE971BF85F6Q33881226-2F8DDFCD-B7F3-427C-B35C-7945E8F5902AQ33895912-005E95D7-26E6-457A-855D-A9E058F018FBQ33924144-E419BD75-BF83-41B0-ADA7-95CC86EEB6D4Q33931354-69209F4C-0F76-4E38-84B2-B7C7F941E6FDQ33939790-1A4B3317-8269-40B3-9853-EF9697A94FF3Q33972588-6F1B307C-919D-4277-B55F-AB95C585B44DQ34117320-EF06FA6A-9261-4238-AEAA-36A69CA409A4Q34208881-D405199F-89A6-4F09-BCA3-7B7C96F00806Q34288644-3E2D36DC-EA1E-40A1-99A2-0A7C5319217EQ34290829-39F025FB-AC8F-4F9A-A1BE-62664DDEB12AQ34329995-3CB12B0F-A2C7-4A3F-9C05-626D8649A659Q34336597-C7EF0951-6830-46E0-B8D4-3C77E3CAF6C4Q34474486-19F4D4F6-381A-4656-92FA-DEF8C8D340FEQ34621520-F5ED1D8F-4381-4517-BB43-96EE01EBAE53Q34621741-EB12EB59-287F-4D0F-8C79-3146BC575651Q34734074-D1652FFF-59DD-4F87-88D5-AF26AEA34E1CQ35108623-0AB3A3A1-6AE8-4F48-A4D8-22C6305D579BQ35164431-9C401630-3C1C-4F47-AFE5-606381A7D544Q35233762-B4FA2397-4553-43DC-B184-8E27A05EA590Q35347960-BACC2A68-5CE3-4F16-900F-F43E0F2F6808Q35586105-78B526F3-FA35-4C34-BB1E-7C9AECFE7550Q35749077-CA5B19E6-8206-46C7-B721-F552991CCBC9Q35819933-6615F334-B22A-4CF7-AF52-17952B115DD8Q35885249-8260F0A2-28C1-4FD6-95AF-77AEDB2199B6Q35981321-926EF6A4-E906-42D8-90FB-A53D617D7EF5Q36027456-537CC962-B5B4-462B-8BA3-D6FA6B21C3B6Q36079853-0130590D-6287-42CF-BB70-AE702DB6B1A2
P2860
A study of proteases and protease-inhibitor complexes in biological fluids.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年学术文章
@wuu
1978年学术文章
@zh-cn
1978年学术文章
@zh-hans
1978年学术文章
@zh-my
1978年学术文章
@zh-sg
1978年學術文章
@yue
1978年學術文章
@zh
1978年學術文章
@zh-hant
name
A study of proteases and protease-inhibitor complexes in biological fluids.
@en
A study of proteases and protease-inhibitor complexes in biological fluids.
@nl
type
label
A study of proteases and protease-inhibitor complexes in biological fluids.
@en
A study of proteases and protease-inhibitor complexes in biological fluids.
@nl
prefLabel
A study of proteases and protease-inhibitor complexes in biological fluids.
@en
A study of proteases and protease-inhibitor complexes in biological fluids.
@nl
P2860
P356
P1476
A study of proteases and protease-inhibitor complexes in biological fluids.
@en
P2093
Granelli-Piperno A
P2860
P304
P356
10.1084/JEM.148.1.223
P407
P577
1978-07-01T00:00:00Z